ASH Preview of the 2017 Meeting on Hematologic Malignancies: Focus on Lymphoma
The ASH Meeting on Hematologic Malignancies includes five core malignant hematology themes: leukemia, lymphoma, myelodysplastic syndromes, myeloproliferative neoplasm, and myeloma. This Focus on Lymphoma webinar features a discussion with two clinicians in the area of Lymphoma regarding how clinical practice has evolved in recent years, as well as discussion of important conclusions from the previous year’s meeting. The doctors also discuss what to expect in the coming year, with emphasis on how "How I Treat" is a different approach than the classic format of educational and or scientific sessions.
The next ASH Meeting on Hematologic Malignancies will be held in Chicago, IL, September 8-9, 2017. The program’s “How I Treat” presentations showcase speakers’ evidence-based treatment approaches, identify cutting-edge scientific data that can be translated into new strategies for diagnosis and treatment, and address what to do in cases where there is no data. This meeting is a unique opportunity to join colleagues and top experts in treatment of hematologic malignancies in an intimate, smaller-meeting setting and discuss the latest drug developments and most relevant research findings advancing patient care today. Visit www.hematology.org/malignancies for information related to next year’s meeting!
Joseph Connors, MD, BC Cancer Agency Centre for Lymphoid Cancer, Vancouver, BC
Jonathan W. Friedberg, MD, MMSc, Wilmot Cancer Institute, University of Rochester, Rochester, NY